Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04862234 · ClinicalTrials.gov registry record · Phase 4
Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients
A Phase 4 study, sponsored by Emory University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT04862234 is a Phase 4 study that was terminated before completion, run by Emory University. The registered enrollment target is 16 participants.
The verdict
NCT04862234, a Phase 4 study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
Hyperglycemia is seen in approximately 30% of patients who do not have a history of diabetes and undergo general surgery. Hyperglycemia in this setting is associated with increased risk of postoperative complications. The purpose of this study is to investigate risk factors for developing high sugars during the time of surgery, and if these high sugars can be prevented by the use of an injectable diabetes medication (dulaglutide) prior to surgery.
Interventions
- DRUG Placebo
- DRUG Dulaglutide
- DEVICE Continuous glucose monitor (CGM), blinded
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-08-06 |
| Est. Completion | 2023-06-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04862234
The ClinicalTrials.gov registry entry for NCT04862234 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04862234 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04862234 about?
NCT04862234 is a clinical study titled "Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients". Hyperglycemia is seen in approximately 30% of patients who do not have a history of diabetes and undergo general surgery. Hyperglycemia in this setting is associated with increased risk of postoperative complications. The purpose of this study is to investigate risk factors for developing high sugar...
What is the current status of trial NCT04862234?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2021-08-06. Estimated completion is 2023-06-22.
What interventions are being tested in trial NCT04862234?
The interventions under investigation include: Placebo (DRUG), Dulaglutide (DRUG), Continuous glucose monitor (CGM), blinded (DEVICE).
Who is sponsoring clinical trial NCT04862234?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.